Leveraging our healthcare network for better access to patients and investigators.
Cardiovascular diseases are now the most common cause of morbidity in the world. According to recent estimates, cases of CVD may
increase from about 290 million in 2000 to as many as 640 million in 2015. Also, there is widespread competition for patients,
sites and investigators for conducting clinical trials.
At SIRO, we leverage our extensive network of investigators and sites to provide you with the most feasible solution for your
product's success. Our network consists of cardiologists and research associates who have an extensive experience in handling
large scale trials globally as well as locally.
Our dedicated 'feasibility team' ensures that the correct investigators and sites are identified for your project while our
'delivery services' team ensures that communication is never a problem.
We have an unprecedented experience in this therapeutic area as we have conducted trials across more than 17,500 sites comprising
of more than 200,000 volunteers.
We have conducted trials in almost every indication in cardiovascular diseases which includes:
Cardiovascular case studies
- Acute decompensated heart failure
- Percutaneous coronary intervention (PCI)
- Myocardial infarction
- Angina pectoris
- And others